Hans Graffner
13Patents
8h-index
11Co-inventors
65Inventor score
Filing activity: Mar 27, 2008 → Oct 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9694018B1 | IBAT inhibitors for the treatment of liver disease | Human Necessities | 43 | Active |
| US9688720B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 24 | Active |
| US10093697B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 20 | Active |
| US10487111B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 19 | Active |
| US10011633B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 16 | Active |
| US10981952B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 16 | Active |
| US10000528B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 15 | Active |
| US11261212B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 13 | Active |
| US11732006B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 8 | Active |
| US10221212B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 8 | Active |
| US8956611B2 | Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease | Human Necessities | 5 | Active |
| US8852591B2 | Combination of BLyS and/or APRIL inhibition and immunosuppressants for treatment of autoimmune disease | Human Necessities | 3 | Active |
| US12187812B2 | IBAT inhibitors for the treatment of liver diseases | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.